Gilead Sciences Inc
Stock Chart, Company Information, and Scan Results
$128.08(as of Nov 19, 3:59 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Gilead Sciences Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$128.08
Ticker SymbolGILD
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - General
Employees17,600
CountyUSA
Market Cap$157,805.8M
EBIDTA14,136.0M
10-Day Moving Average123.59
P/E Ratio19.80
20-Day Moving Average122.02
Forward P/E Ratio14.12
50-Day Moving Average118.06
Earnings per Share6.46
200-Day Moving Average110.68
Profit Margin39.28%
RSI66.80
Shares Outstanding1,240.7M
ATR3.34
52-Week High128.10
Volume6,732,437
52-Week Low85.52
Book Value21,456.0M
P/B Ratio7.49
Upper Keltner129.54
P/S Ratio5.52
Lower Keltner114.49
Debt-to-Equity Ratio129.54
Next Earnings DateUnknown
Cash Surplus-4,967.0M
Next Ex-Dividend Date12/15/2025
Add good karma to your portfolio with GILD. This research-based biopharmaceutical company is making the world a better place by developing and commercializing medicines for life-threatening diseases like HIV/AIDS, liver diseases, and cancer. Gilead’s HIV treatments, including Truvada and Atripla, have helped transform the chronic disease into a manageable condition. Their treatments are responsible for saving millions of lives.
Gilead Sciences Inc In Our Stock Scanner
As of Nov 20, 2025
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Scan Name: 52-Week HighScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.